Thought Leader, Care Redesign

Russell Rothman, MD, MPP

Professor, Internal Medicine, Pediatrics, & Health Policy; Vice President for Population Health Research
Vanderbilt University; Vanderbilt University Medical Center

Dr. Rothman is a Professor of Internal Medicine, Pediatrics and Health Policy, and the Vice President for Population Health Research at Vanderbilt University Medical Center. He also serves as the Director of the Vanderbilt Center for Health Services Research and Chief of the Internal Medicine/Pediatrics Section. Dr. Rothman’s current research focuses on improving care for adult and pediatric patients with diabetes, obesity, and other chronic diseases. His research has focused on addressing health communication, health literacy/numeracy, and other social and behavior factors to improve health. As Director of the Vanderbilt Center for Health Services Research, Dr. Rothman oversees a Center that engages over 150 faculty across the university engaged in over $50 million annual of funded research related to health services research, implementation science, behavioral research, health disparities research, quality improvement research, and other areas aimed at improving health outcomes. He has been the Principal Investigator on over $45 million in extramural funding and has authored over 130 manuscripts. He is currently the Principal Investigator of the PCORI-funded Mid-South Clinical Data Research Network, which engages over 50 hospitals and thousands of ambulatory practices reaching patients across the nation. He is also PI of the CMS-funded Mid-South Practice Transformation Network, which engages 4,000 clinicians in quality improvement. Dr. Rothman also serves on the PCORI PCORnet Executive Steering Committee, which oversees the development of a national network to support comparative effectiveness research and pragmatic clinical trials, with over $250 million committed from PCORI to date. Dr. Rothman serves as the Co-Chair of the Steering Committee of the ADAPTABLE study, a pragmatic clinical trial enrolling 15,000 patients to evaluate the optimal dose of aspirin in secondary prevention of heart disease. Dr. Rothman is also the President-elect of the Academy of Communication in Healthcare (ACH).

Insights Council

Have a voice. Join other health care leaders effecting change, shaping tomorrow.

Apply Now